Evidence check: Hormoncheck Frauen in the context of Wechseljahre

Hormone check panels marketed to women during menopause often promise personalized insights into hormone balance. However, the scientific evidence supporting their routine use is weak. Hormone levels such as estradiol, FSH, and progesterone fluctuate significantly – by time of day, menstrual cycle phase, and laboratory method. A single measurement does not reliably diagnose menopausal stage or predict symptoms. Clinical guidelines (e.g., from the North American Menopause Society) do not recommend routine hormone testing for perimenopause diagnosis; instead, diagnosis is based on age, menstrual patterns, and symptom history. Direct-to-consumer (DTC) tests frequently overstate their predictive power and may lead to unnecessary anxiety or inappropriate treatments. Independent validation studies for many of these panels are lacking. Hormone testing is only clinically indicated in specific scenarios (e.g., suspected premature menopause, fertility assessment) under medical supervision. In summary, the evidence for generic hormone checks in menopause is largely marketing-driven; consumers should approach such tests with caution and consult a healthcare professional.